These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 13332558)

  • 1. Blockade by brom-lysergic-acid-diethylamide (BOL) of the potentiating action of serotonin and reserpine on hexobarbital hypnosis.
    SALMOIRAGHI GC; SOLLERO L; PAGE IH
    J Pharmacol Exp Ther; 1956 Jun; 117(2):166-8. PubMed ID: 13332558
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain.
    SHORE PA; SILVER SL; BRODIE BB
    Science; 1955 Aug; 122(3163):284-5. PubMed ID: 13246633
    [No Abstract]   [Full Text] [Related]  

  • 3. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].
    GIBERTI F; GREGORETTI L
    Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin as a mediator of reserpine action in brain.
    PLETSCHER A; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1956 Jan; 116(1):84-9. PubMed ID: 13296021
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of LSD 25, BOL 148, bufotenine, mescaline and ibogaine on the potentiation of hexobarbital hypnosis produced by serotonin and reserpine.
    SALMOIRAGHI GC; PAGE IH
    J Pharmacol Exp Ther; 1957 May; 120(1):20-5. PubMed ID: 13449697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Specific inhibition of serotonin effects by lysergic acid diethylamide and similar compounds].
    CERLETTI A; KONZETT H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146-8. PubMed ID: 13334586
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological analysis of psychotogenic drug action. I. Effect of LSD on specific afferent systems in the cat.
    PURPURA DP
    AMA Arch Neurol Psychiatry; 1956 Feb; 75(2):122-31. PubMed ID: 13282532
    [No Abstract]   [Full Text] [Related]  

  • 8. The acute effects of reserpine and of amytal on central sympathetic reactivity.
    SCHNEIDER RA
    Ann N Y Acad Sci; 1955 Apr; 61(1):150-60. PubMed ID: 14377282
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulatory interactions of serotonin and reserpine (serpasil) in dogs.
    SCHNEIDER JA; RINEHART RK
    Arch Int Pharmacodyn Ther; 1956 Mar; 105(3-4):253-68. PubMed ID: 13314734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anaphylactic reactions in the isolated guinea pig auricle preparation and their influencing by antihistaminics. BOL, dihydroergotamine and reserpine].
    GREEFF K; BENFEY BG; BOKELMANN A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 236():421-34. PubMed ID: 13829189
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of hallucinogenic and tranquilizing drugs on the serotonin-evoked uterine contractions.
    COSTA E
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Apr; (4):11-23. PubMed ID: 13323108
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.
    GADDUM JH
    J Physiol; 1953 Jul; 121(1):15P. PubMed ID: 13085323
    [No Abstract]   [Full Text] [Related]  

  • 13. Brom-lysergic acid diethylamide: a highly potent serotonin antagonist.
    SOLLERO L; PAGE IH; SALMOIRAGHI GC
    J Pharmacol Exp Ther; 1956 May; 117(1):10-5. PubMed ID: 13320295
    [No Abstract]   [Full Text] [Related]  

  • 14. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin release as a possible mechanism of reserpine action.
    PLETSCHER A; SHORE PA; BRODIE BB
    Science; 1955 Aug; 122(3165):374-5. PubMed ID: 13246642
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system.
    SHORE PA; SILVER SL; BRODIE BB
    Experientia; 1955 Jul; 11(7):272-3. PubMed ID: 13241495
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substances interfering with the hypnotic-potentiating activity of serotonin].
    GARATTINI S; VALZELLI L
    Boll Soc Ital Biol Sper; 1956; 32(3-5):292-5. PubMed ID: 13342261
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of intraventricular injection of d-lysergic acid diethylamide (LSD 25) and 5-hydroxytryptamine (serotonin) on the electrical activity of the brain of the conscious cat.
    BRADLEY PB; HANCE AJ
    J Physiol; 1956 May; 132(2):50-1P. PubMed ID: 13320431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of 5-hydroxy tryptamin (serotonin) and lysergic acid diethylamide (LSD) on the pituitary-adrenal cortex system].
    MILKOVIC S; SUPEK Z
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146. PubMed ID: 13334585
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antagonism of serotonin on one side and chlorpromazine and reserpine on the other].
    GARATTINI S; VALZELLI L
    Boll Soc Ital Biol Sper; 1955; 31(11-12):1648-52. PubMed ID: 13329252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.